OTC: MDCLF - MedinCell S.A.

Lønnsomhet i seks måneder: 0%
Sektor: Healthcare

Kampanjeplan MedinCell S.A.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

MedinCell S.A. develops various therapeutic solutions in France. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients.

Flere detaljer
The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension completed Phase III trial for use in the treatment of schizophrenia; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain & inflammation; and mdc-TJK, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials, such as mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for use in organ transplant; mdc-WWM for contraception; mdc-STM for use in malaria; mdc-KPT for use in acute pain for pets; and mdc-IRM for use in neuroscience. The company was incorporated in 2003 and is based in Jacou, France.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0135
EV/EBITDA -0.3778
Industry Biotechnology
P/BV 33.64
P/S 36.64
Sector Health Care
Валюта usd
Валюта отчета eur
Выручка 0.0013
Сайт https://www.medincell.com
Цена ао 6.98
Число акций ао 0.02519 млрд
Prisendring per dag: 0% (6.976)
Prisendring per uke: 0% (6.976)
Prisendring per måned: 0% (6.976)
Prisendring over 3 måneder: 0% (6.976)
Prisendring over seks måneder: 0% (6.976)
Prisendring per år: 0% (6.976)
Prisendring over 3 år: -50.17% (14)
Prisendring over 5 år: 0% (6.976)
Prisendring over 10 år: 0% (6.976)
Prisendring siden begynnelsen av året: 0% (6.976)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 19.97 1
P/BV -4.48 0
P/E 0 0
EV/EBITDA -11.95 0
Total: 2.63

Effektivitet

Navn Betydning Karakter
ROA, % -75.54 0
ROE, % 60.25 10
Total: 1.67

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -3.17 10
Total: 9.4

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 221.18 10
Lønnsomhet Ebitda, % 3.76 1
Lønnsomhet EPS, % -35.02 0
Total: 2.4
Flere detaljer

Institusjoner Volum Dele, %
American Funds Insurance Ser-Global Small Capitalization Fund 397121 1.58



Veileder Stillingstittel Betaling Fødselsår
Mr. Christophe Douat Chief Executive Officer & Director 427.7k 1966 (58 år)
Mr. Franck Pouzache Chief People Officer & Member of the Management Board 216.57k
Julie Alimi Head of Legal N/A
Mr. David Heuze Head of Communications N/A
Mr. Adolfo Lopez-Noriega Head of Research & Development N/A
Mr. Sebastien Enault Chief Business Officer N/A
Ms. Helen Martin Head of Alliance & Project Management N/A
Ms. Quiterie De Beauregard Head of Global Health Development N/A
Dr. Richard Malamut M.D. Chief Medical Officer N/A 1960 (64 år)
Mr. Stephane Postic Chief Financial Officer

Adresse: France, Jacou, 3 rue des Frères Lumière - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.medincell.com